Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D S Postma

Showing results (121-130 of 446) with videos related to

Pageof 45
Sort By:
Allergy|November 18, 2003
Allergic sensitization to indoor and outdoor allergens and relevance to bronchial hyperresponsiveness in younger and older subjectsM Kerkhof, D S Postma, J P Schouten, et al.
The European Respiratory Journal|May 1, 1988
The relationship between reversibility and hyperreactivityD S Postma, N de Graaf-Breederveld, G H Koëter, et al.
American Journal of Respiratory and Critical Care Medicine|November 14, 1997
Treatment of nocturnal airway obstruction improves daytime cognitive performance in asthmaticsE J Weersink, E H van Zomeren, G H Koëter, et al.
Bulletin Europeen De Physiopathologie Respiratoire|January 1, 1986
The beta-adrenergic receptor and bronchial hyperreactivityG H Koeter, H Meurs, J Kraan, et al.
Experimental Hematology|February 1, 1996
Activation of the cAMP-dependent signaling pathway downregulates the expression of interleukin-3 and granulocyte-macrophage colony-stimulating factor in activated human T lymphocytesP Borger, H F Kauffman, J L Vijgen, et al.
The European Respiratory Journal|March 4, 2000
Budesonide and formoterol inhibit ICAM-1 and VCAM-1 expression of human lung fibroblastsF M Spoelstra, D S Postma, H Hovenga, et al.
Lancet (London, England)|November 10, 2000
Histamine airway hyper-responsiveness and mortality from chronic obstructive pulmonary disease: a cohort studyJ J Hospers, D S Postma, B Rijcken, et al.
American Journal of Respiratory and Critical Care Medicine|July 9, 1998
Starting with a higher dose of inhaled corticosteroids in primary care asthma treatmentT van der Molen, B Meyboom-de Jong, H H Mulder, et al.
Immunology|December 3, 1999
Nitric oxide selectively decreases interferon-gamma expression by activated human T lymphocytes via a cGMP-independent mechanismR Roozendaal, E Vellenga, D S Postma, et al.
The European Respiratory Journal|November 26, 1999
Interferon-gamma and interleukin-4 differentially regulate ICAM-1 and VCAM-1 expression on human lung fibroblastsF M Spoelstra, D S Postma, H Hovenga, et al.
Pageof 45

Showing results (121-130 of 446) with videos related to

Sort By:
Pageof 45
Allergy|November 18, 2003
Allergic sensitization to indoor and outdoor allergens and relevance to bronchial hyperresponsiveness in younger and older subjectsM Kerkhof, D S Postma, J P Schouten, et al.
The European Respiratory Journal|May 1, 1988
The relationship between reversibility and hyperreactivityD S Postma, N de Graaf-Breederveld, G H Koëter, et al.
American Journal of Respiratory and Critical Care Medicine|November 14, 1997
Treatment of nocturnal airway obstruction improves daytime cognitive performance in asthmaticsE J Weersink, E H van Zomeren, G H Koëter, et al.
Bulletin Europeen De Physiopathologie Respiratoire|January 1, 1986
The beta-adrenergic receptor and bronchial hyperreactivityG H Koeter, H Meurs, J Kraan, et al.
Experimental Hematology|February 1, 1996
Activation of the cAMP-dependent signaling pathway downregulates the expression of interleukin-3 and granulocyte-macrophage colony-stimulating factor in activated human T lymphocytesP Borger, H F Kauffman, J L Vijgen, et al.
The European Respiratory Journal|March 4, 2000
Budesonide and formoterol inhibit ICAM-1 and VCAM-1 expression of human lung fibroblastsF M Spoelstra, D S Postma, H Hovenga, et al.
Lancet (London, England)|November 10, 2000
Histamine airway hyper-responsiveness and mortality from chronic obstructive pulmonary disease: a cohort studyJ J Hospers, D S Postma, B Rijcken, et al.
American Journal of Respiratory and Critical Care Medicine|July 9, 1998
Starting with a higher dose of inhaled corticosteroids in primary care asthma treatmentT van der Molen, B Meyboom-de Jong, H H Mulder, et al.
Immunology|December 3, 1999
Nitric oxide selectively decreases interferon-gamma expression by activated human T lymphocytes via a cGMP-independent mechanismR Roozendaal, E Vellenga, D S Postma, et al.
The European Respiratory Journal|November 26, 1999
Interferon-gamma and interleukin-4 differentially regulate ICAM-1 and VCAM-1 expression on human lung fibroblastsF M Spoelstra, D S Postma, H Hovenga, et al.
Pageof 45